The world is amidst a profound demographic transformation, with aging populations commanding attention. By 2030, the 60-and-above demographic is set to swell by over one-third, surpassing children ...
Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizations reduced by 69% in Spain following Beyfortus-only immunization targeted to all infants and 26.7% in the UK following ...
Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type ...
The Business Research Company's Meningococcal Disease Vaccine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores ...
Vaccines are one of public health's greatest triumphs, preventing millions of cases of deadly diseases worldwide. Yet gaps in coverage, waning immunity, and vaccine hesitancy mean preventable ...
Protecting the health of Americans means strong state and local-level immunization programs, coupled with initiatives that prioritize limiting the international importation of vaccine-preventable ...
Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Shingles Vaccine Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The shingles vaccine market size has grown rapidly in ...
Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizations reduced by 69% in Spain following Beyfortus-only immunization targeted to all infants and 26.7% in the UK following ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback